Search Results - "Tuncer, A.Murat"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Evaluation of low-to-moderate arsenic exposure, metabolism and skin lesions in a Turkish rural population exposed through drinking water by Alshana, Usama, Altun, Beril, Ertaş, Nusret, Çakmak, Gonca, Kadioglu, Ela, Hisarlı, Deniz, Aşık, Elif, Atabey, Eşref, Çelebi, Celalettin Rumi, Bilir, Nazmi, Serçe, Hakan, Tuncer, A.Murat, Burgaz, Sema

    Published in Chemosphere (Oxford) (01-10-2022)
    “…There is no human data regarding the exposure, metabolism and potential health effects of arsenic (As) contamination in drinking water in the Central Anatolian…”
    Get full text
    Journal Article
  2. 2

    Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment by Hiçsönmez, Gönül, Çetin, Mualla, Tuncer, A.Murat, Yenicesu, İdil, Aslan, Deniz, Özyürek, Emel, Ünal, Selma

    Published in Leukemia research (01-01-2004)
    “…To evaluate whether children with acute myeloblastic leukemia (AML) presenting with extramedullary infiltration (EMI) have different clinical, morphologic…”
    Get full text
    Journal Article
  3. 3

    Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study by Özbek, Namık, Yetgin, Sevgi, Tuncer, A.Murat

    Published in Leukemia research (2000)
    “…Several agents, used either alone or in combination, have been shown to boost absolute numbers of PMLs and CD34 + stem cells in PB. In this study, we compared…”
    Get full text
    Journal Article
  4. 4

    The importance of cell size and surface marker analysis in childhood acute myeloblastic leukemia by Olcay, Lale, Ertem, Ulya, Okur, Hamza, Tuncer, A.Murat

    Published in Leukemia research (01-08-1999)
    “…In order to evaluate the prognostic significance of cell size and surface marker expression, we evaluated 33 children with newly diagnosed acute myeloblastic…”
    Get full text
    Journal Article
  5. 5

    Effect of short-course high-dose methylprednisolone treatment on serum IL-2 levels in children with myelodysplastic syndromes: A pilot study by Yenicesu, Idil, Hiçsönmez, Gönül, Tuncer, A.Murat

    Published in Leukemia research (01-08-1997)
    “…Promising results in children with myelodysplastic syndromes (MDS) have been reported with high-dose methylprednisolone (HDMP) as a differentiation inducer,…”
    Get full text
    Journal Article
  6. 6
  7. 7